Sharekhan
- New Delhi Safdarjung Enclave Branch
- No C1, 1st Floor
Green Park Extension
New Delhi - 110016 -
- Opens at 08:30 AM
- Fri 08:30 AM - 06:30 PM
- Sat 08:30 AM - 06:30 PM
- Sun 08:30 AM - 06:30 PM
- Opens at 08:30 AM
- Call Get Directions
#SharekhanFNA #Wipro Q3FY22 results review: Q3 revenue missed estimates, but margin in-line; provided revenue growt… https://t.co/nE4NNaBdL5 #SharekhanFNA #Wipro
#SharekhanFNA #SharekhanResearch retains Buy on #Cadila (PT Rs720) India bizz on a strong footing to stage a double… https://t.co/p7fQwP0Ohw #SharekhanFNA #SharekhanResearch #Cadila
#SharekhanFNA #SharekhanResearch retains Buy on #AbbottIndia (PT Rs22780) Co to sustain double digit growth traject… https://t.co/LVEkhnOInj #SharekhanFNA #SharekhanResearch #AbbottIndia
#SharekhanFNA #SharekhanResearch retains Buy rating on #TorrentPharma (PT Rs3620) Strong growth outlook exists for… https://t.co/oIUsjvIR10 #SharekhanFNA #SharekhanResearch #TorrentPharma
#SharekhanFNA #SharekhanResearch retains Positive view on #CaplinPoint (Upside 30%) Co relatively less impacted by… https://t.co/aajLXTmNIf #SharekhanFNA #SharekhanResearch #CaplinPoint
#SharekhanFNA #SharekhanResearch retains Buy on #GlandPharma (PT Rs 4400) strng gwth in RoW mkts with rev share lik… https://t.co/GDqGHYQGHB #SharekhanFNA #SharekhanResearch #GlandPharma
#SharekhanFNA #SharekhanResearch retains Buy on #IPCALabs (PT Rs 2675) acquisition of stake in #Lykalabs & a Jt mng… https://t.co/WzcJlnN8p0 #SharekhanFNA #SharekhanResearch #IPCALabs #Lykalabs
#SharekhanFNA #SharekhanResearch #Q2FY22 Pharma Review; mixed qtr, results driven by strng gwth in India bizz, US g… https://t.co/0ZNFTKdAGn #SharekhanFNA #SharekhanResearch #Q2FY22
#SharekhanFNA #SharekhanResearch retains Buy on #SolaraActivePharma (PT Rs 1615) #Q2FY22 was weak qtr rslts missed… https://t.co/CXVPfcqpSV #SharekhanFNA #SharekhanResearch #SolaraActivePharma #Q2FY22
On our website, we use services (including from third-party providers) that help us to improve our online presence (optimization of website) and to display content that is geared to their interests. We need your consent before being able to use these services.